ELREXFIO Trademark

Trademark Overview

On Friday, April 16, 2021, a trademark application was filed for ELREXFIO with the United States Patent and Trademark Office. The USPTO has given the ELREXFIO trademark a serial number of 90651029. The federal status of this trademark filing is REGISTERED as of Tuesday, December 5, 2023. This trademark is owned by Pfizer Inc.. The ELREXFIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer and blood disorders
elrexfio

General Information

Serial Number90651029
Word MarkELREXFIO
Filing DateFriday, April 16, 2021
Status700 - REGISTERED
Status DateTuesday, December 5, 2023
Registration Number7236993
Registration DateTuesday, December 5, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 11, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer and blood disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 24, 2021
Primary Code005
First Use Anywhere DateThursday, August 31, 2023
First Use In Commerce DateThursday, August 31, 2023

Trademark Owner History

Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, December 5, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 5, 2023REGISTERED-PRINCIPAL REGISTER
Friday, November 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 3, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, November 2, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, November 2, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, October 23, 2023USE AMENDMENT FILED
Thursday, November 2, 2023SOU EXTENSION 4 GRANTED
Monday, October 23, 2023SOU EXTENSION 4 FILED
Monday, October 30, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 23, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 23, 2023TEAS STATEMENT OF USE RECEIVED
Saturday, July 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 27, 2023SOU EXTENSION 3 GRANTED
Thursday, July 27, 2023SOU EXTENSION 3 FILED
Thursday, July 27, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 28, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, January 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 26, 2023SOU EXTENSION 2 GRANTED
Thursday, January 26, 2023SOU EXTENSION 2 FILED
Thursday, January 26, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 8, 2022SOU EXTENSION 1 GRANTED
Monday, August 8, 2022SOU EXTENSION 1 FILED
Monday, August 8, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, March 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 11, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 11, 2022PUBLISHED FOR OPPOSITION
Wednesday, December 22, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 2, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 2, 2021ASSIGNED TO EXAMINER
Saturday, July 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 20, 2021NEW APPLICATION ENTERED

Related Keywords

elrexfio blood disorders cancer treatment preparations pharmaceutical